LPMed staff has a long record of research in the field of colorectal cancer tumorigenesis. Since colorectal cancer is by incidence one of the most common cancers in Croatia as well as worldwide this laboratory is an important constituent of the Cancer Research Programme at the IRB.

LPMed has over the years acquired a substantial amount of tumour samples from Croatian patients suffering from sporadic colorectal cancer and has a good collaboration with clinics. These samples are part of the Croatian Tumour and DNA bank at the Department for Molecular Medicine.

In addition, LPMed offers the service of molecular testing for hereditary gastrointestinal cancer (FAP, HNPCC), hereditary and somatic pharmacogenetic markers as well as for the neurofibromatosis type I.

This site uses cookies.

Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.